City

Bethesda (1)

Condition

Advanced Solid Tumors (1)

HRD Cancer (1)

SCLC (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

berzosertib (1)

sacituzumab govitecan (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

hrd cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting

HRD Cancer
+2 more

Berzosertib
Sacituzumab Govitecan

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 20, 2023